MCA
PFE icon

Magnolia Capital Advisors’s Pfizer PFE Stock Holding History

Magnolia Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392K Buy
16,265
+705
+5% +$18.4K 0.07% 218
2026
Q1 		$437K Buy
15,560
+2,848
+22% +$75.8K 0.09% 214
2025
Q4 		$317K Buy
12,712
+2,429
+24% +$61.3K 0.07% 229
2025
Q3 		$262K Sell
10,283
-734
-7% -$18.1K 0.07% 205
2025
Q2 		$267K Buy
11,017
+248
+2% +$5.78K 0.07% 205
2025
Q1 		$273K Sell
10,769
-9,652
-47% -$253K 0.07% 199
2024
Q4 		$542K Buy
20,421
+11,975
+142% +$325K 0.14% 153
2024
Q3 		$244K Buy
+8,446
New +$246K 0.12% 128
2023
Q3 		– Sell
-12,390
Closed -$454K – 121
2023
Q2 		$454K Buy
12,390
+283
+2% +$11K 0.23% 89
2023
Q1 		$494K Sell
12,107
-200
-2% -$8.64K 0.25% 94
2022
Q4 		$631K Buy
12,307
+172
+1% +$8.25K 0.42% 68
2022
Q3 		$531K Sell
12,135
-1,380
-10% -$67.1K 0.45% 64
2022
Q2 		$708K Sell
13,515
-1,299
-9% -$66.2K 0.64% 53
2022
Q1 		$767K Buy
14,814
+201
+1% +$10.4K 0.3% 88
2021
Q4 		$863K Buy
14,613
+805
+6% +$39.9K 0.25% 80
2021
Q3 		$594K Sell
13,808
-1,564
-10% -$69.3K 0.21% 97
2021
Q2 		$602K Buy
+15,372
New +$598K 0.27% 71
2021
Q1 		– Sell
-13,396
Closed -$493K – 113
2020
Q4 		$493K Sell
13,396
-581
-4% -$21.3K 0.32% 52
2020
Q3 		$487K Sell
13,977
-852
-6% -$29.9K 0.38% 44
2020
Q2 		$460K Sell
14,829
-4,399
-23% -$149K 0.59% 32
2020
Q1 		$595K Buy
19,228
+1,503
+8% +$51.2K 1.15% 23
2019
Q4 		$658K Buy
+17,725
New +$631K 0.63% 30

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Magnolia Capital Advisors's PFE Position: Q2 2026 in Review

Magnolia Capital Advisors increased its Pfizer (PFE) stake by 4.5% in Q2 2026, buying an estimated $18.4K and bringing the position to 16,265 shares worth $392K. The position accounts for 0.07% of the portfolio, ranked #218.

Magnolia Capital Advisors first reported a position in PFE in Q4 2019 and has held it in 22 quarters since. The position peaked at $863K in Q4 2021. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Magnolia Capital Advisors held 16,265 shares of Pfizer worth $392K as of Q2 2026.
  • Magnolia Capital Advisors bought 705 Pfizer shares in Q2 2026, an estimated $18.4K.
  • Pfizer made up 0.07% of Magnolia Capital Advisors's portfolio in Q2 2026, its #218 holding.
  • Magnolia Capital Advisors first reported a position in Pfizer in Q4 2019 and has held it in 22 quarters since.
  • Magnolia Capital Advisors's Pfizer position peaked at $863K in Q4 2021.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Magnolia Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.